Glycosaminoglycans in crystal-surface binding substances and their role in calcium oxalate crystal growth

British Journal of Urology

Volumn 80, Issue 1, 1997, Pages 64-68

  Yoshimura, K ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Calcium oxalate; Crystal growth; Crystal surface binding substances; Dermatan sulphate; Glycosaminoglycans; Heparan sulphate; Inhibitor

Indexed keywords

CALCIUM OXALATE; DERMATAN SULFATE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; PROTEINASE;

ADULT; ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; CRYSTALLIZATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; URINALYSIS;

EID: 0031400892     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.1997.00189.x     Document Type: Article

References (19)

1. Nakagawa Y, Abram V, Kezdy FJ, Kaiser ET, Coe PL. Purification and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine. J Biol Chem 1983; 258: 12594-600
2. Hess B, Nakagawa Y, Coe FL. Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins. Am J Physiol 1989: 257: F99
3. Sorensen S, Justesen SJ, Johnsen AH Identification of a macromolecular crystal growth inhibitor in human urine as osteopontin. Urol Res 1995: 23: 327-34
4. Stapleton AMP, Ryall RL. Blood coagulation proteins and urolithiasis are linked: crystal matrix protein is the Fl activation peptide of human prothrombin. Br ) Urol 1995; 75: 712-9
5. Atmani F. Lacour B, Drucke T, Daudon M. Isolation and purification of a new glycoprotein from human urine inhibiting calcium oxalate crystallization. Urol Res 1993; 21: 61-6
6. Shiraga H. Min W. Van Dusen W] et al. Inhibition of calcium oxalate crystal growth in vitro by uropontin. Another member of the aspartic acid-rich protein superfamily. Proc Natl Acad Sei USA 1992; 89: 426-30
7. Goldberg JM. Collier E. Specific isolation and analysis of mucopolysaccharides (glycosaminoglycans) from human urine. Clin Chim Acta 1972; 41: 19-27
8. Varadi DP. Citronelli JA, Dortman A. The acid mucopolysaccharides of normal urine. Biochem Biophys Acta 1967; 141: 103-17
9. Wessler E. The nature of the non-ultrafiltrable glycosaminoglycans of normal human urine. Biochem J 1971; 122: 373-84
10. Nishio S, Abe Y, Wakatsuki A et al. Matrix glycosaminoglycan in urinary stones. J Urol 1985; 134: 503-5
11. Koide T, Yoshioka T, Yamaguchi S, Hosokawa S, Utsunomiya M, Sonoda T. Urinary crystal surface binding substances on calcium oxalate crystals. Urol Res 1990; 18: 387-92
12. Yamaguchi S, Yoshioka T, Utsunomiya M et al. Heparan sulfate in the stone matrix and its inhibitory effect on calcium oxalate crystallization. Urol Res 1993; 21: 187-92
13. Farndale RW. Sayers CA, Barrett AJ. A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. Conn Tiss Res 1982; 9: 247-8
14. Bradford MM. A rapid and sensitive method for the quantificaton of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-51
15. Robertson WG, Peacook M, Nordin BEC. Inhibitors of the growth and aggregation of calcium oxalate crystal in vitro. Clin Chim Acta 1973; 43: 31-7
16. Boyce WH. Organic matrix of human urinary concretions. Am] Med 1968; 45: 673-83
17. Suzuki K. Mayne K. Doyle IR, Ryall RL. Urinary glycosaminoglycans are selectively induced into calcium oxalate crystals precipitated from whole human urine. Scan Microsc 1994; 8: 523-30
18. Roberts SD, Resnick MI. Glycosaminoglycan content of stone matrix. J Urol 1986; 135: 1078-83
19. Verkoelen CF. Romijn JC, Cao LC, Boeve ER, De Bruijn WC, Schroder FH. Crystal-cell interaction inhibition by polysaccharides. J Urol 1996; 155: 749-52